Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
Department of Obstetrics and Gynecology, Tokyo University Graduate School of Medicine, Tokyo 113-0033, Japan.
Int J Mol Sci. 2019 Aug 30;20(17):4246. doi: 10.3390/ijms20174246.
Preeclampsia, a systemic vascular disorder characterized by new-onset hypertension and proteinuria after 20 weeks of gestation, is the leading cause of maternal and perinatal morbidity and mortality. Maternal endothelial dysfunction caused by placental factors has long been accepted with respect to the pathophysiology of preeclampsia. Over the past decade, increased production of placental antiangiogenic factors has been identified as a placental factor leading to maternal endothelial dysfunction and systemic vascular dysfunction. This review summarizes the recent advances in understanding the molecular mechanisms of endothelial dysfunction caused by placental antiangiogenic factors, and the novel clinical strategies based on these discoveries.
子痫前期是一种系统性血管疾病,其特征是在妊娠 20 周后出现新发生的高血压和蛋白尿,是孕产妇和围产儿发病率和死亡率的主要原因。长期以来,人们一直认为胎盘因素引起的母体内皮功能障碍是子痫前期的病理生理学基础。在过去的十年中,人们已经确定胎盘抗血管生成因子的过度产生是导致母体内皮功能障碍和全身血管功能障碍的胎盘因素。本综述总结了目前对胎盘抗血管生成因子引起的内皮功能障碍的分子机制的理解进展,以及基于这些发现的新的临床策略。